Sono-Tek (NASDAQ:SOTK) Releases Earnings Results, Misses Expectations By $0.02 EPS

Sono-Tek (NASDAQ:SOTK) issued its quarterly earnings results on Wednesday. The industrial products company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.02), FiscalAI reports. The company had revenue of $5.23 million for the quarter, compared to analysts’ expectations of $5.54 million. Sono-Tek had a return on equity of 10.55% and a net margin of 9.62%.

Here are the key takeaways from Sono-Tek’s conference call:

• First-half results improved: Revenue rose 6% to approximately $10.9 million, gross margin expanded to 55% from 51%, operating income increased 41%, and net income grew 22%.
• Medical demand accelerated sharply, with sales up 289% to approximately $7.1 million as customers transitioned from development to commercial production of drug-eluting balloons, stents, and other medical devices.
• Sono-Tek received a record $7.19 million order for 10 alternative-energy production systems, adding to a medical diagnostic order exceeding $3.6 million; most of this more than $10.79 million in business is expected to ship in fiscal 2028.
• Management reiterated its expectation for flat to modest revenue growth in fiscal 2027, citing quarter-to-quarter volatility from the timing of large system shipments, while saying the recent orders improve visibility for fiscal 2028.
• The company plans to expand manufacturing capacity from roughly $27 million to $33 million–$36 million initially, with a potential later expansion to approximately $44 million–$45 million; initial capital spending is estimated at about $700,000.

Sono-Tek Stock Down 12.9%

SOTK stock opened at $6.20 on Thursday. The stock has a market capitalization of $97.46 million, a price-to-earnings ratio of 47.70 and a beta of 0.07. Sono-Tek has a 52-week low of $3.40 and a 52-week high of $7.48. The stock’s fifty day simple moving average is $5.34 and its 200-day simple moving average is $5.09.

Insiders Place Their Bets

In related news, CFO Stephen Bagley sold 8,346 shares of Sono-Tek stock in a transaction on Thursday, July 30th. The stock was sold at an average price of $5.13, for a total value of $42,814.98. Following the transaction, the chief financial officer owned 21,254 shares in the company, valued at approximately $109,033.02. This trade represents a 28.20% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold a total of 13,000 shares of company stock worth $67,666 over the last quarter. Company insiders own 5.57% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Weiss Ratings raised Sono-Tek from a “hold (c+)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Wall Street Zen upgraded shares of Sono-Tek to a “strong-buy” rating in a research note on Sunday, July 12th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $8.50.

Key Stories Impacting Sono-Tek

Here are the key news stories impacting Sono-Tek this week:

• Positive Sentiment: First-half revenue increased 6% to $10.9 million, while operating income rose 41% and gross margin expanded to 55%. Medical-market sales surged 289% to $7.05 million, highlighting growing demand for Sono-Tek’s precision coating systems. Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results
• Positive Sentiment: The company reported a $9.51 million equipment and service backlog at the quarter-end, followed by approximately $7.19 million of additional orders expected to ship in fiscal 2028. Management said these orders improve future revenue visibility. Sono-Tek Q2 Revenue Rises 1% to $5.23 Million
• Positive Sentiment: Sono-Tek outlined a facility expansion intended to raise manufacturing capacity to $33 million-$36 million, with a longer-term plan targeting $44 million-$45 million. The investment could support growth if demand continues to build. Sono-Tek Facility Expansion
• Neutral Sentiment: Management maintained its fiscal 2027 outlook for flat to modest revenue growth, citing the timing of several large orders. Sono-Tek ended the quarter with $17.7 million in cash, cash equivalents and marketable securities and no debt. Sono-Tek Fiscal 2027 Results
• Negative Sentiment: Second-quarter earnings were $0.02 per share versus analyst estimates of roughly $0.04-$0.05, while revenue of $5.23 million was below the $5.54 million consensus. Net income declined from the prior-year quarter, making the results a significant near-term earnings disappointment. Sono-Tek Misses Q2 Estimates

About Sono-Tek

Sono-Tek Corporation develops and manufactures ultrasonic coating and precision liquid-deposition systems. Its technology uses high-frequency sound waves to atomize liquids into a controlled spray, enabling uniform application of coatings, adhesives, lubricants, and other materials while minimizing overspray and material waste.

The company’s products include ultrasonic spray nozzles, integrated coating systems, and customized solutions designed for automated manufacturing processes. Sono-Tek also provides application development, process optimization, installation, training, and technical support to help customers integrate its equipment into production lines.

Sono-Tek’s systems are used across a range of industries, including medical devices, electronics, semiconductor and advanced technology manufacturing, alternative energy, glass, textiles, and other industrial applications.